Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

被引：0
|
作者：
Phyllis Chan
Jiajie Yu
Leslie Chinn
Marita Prohn
Jan Huisman
Brett Matzuka
William Hanley
Katie Tuckwell
Angelica Quartino
机构：
[1] Clinical Pharmacology,Clinical Sciences
[2] qPharmetra,undefined
[3] qPharmetra,undefined
[4] Former Genentech employee,undefined
[5] currently of Seattle Genetics,undefined
[6] Early Clinical Development,undefined
来源：
Pharmaceutical Research | 2020年 / 37卷 / 2期
关键词：
Bruton’s tyrosine kinase (BTK) inhibitor; exposure-response; model-based meta-analysis; population pharmacokinetics; rheumatoid arthritis;
D O I：
10.1007/s11095-019-2752-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects
    Ricardo Nalda-Molina
    Belén Valenzuela
    Amelia Ramon-Lopez
    Bernardo Miguel-Lillo
    Arturo Soto-Matos
    Juan Jose Perez-Ruixo
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 97 - 108
  • [32] Population pharmacokinetics of ainuovirine and exposure-response analysis in the HIV-infected individuals
    Su Bin
    Sun Jin
    Zhang Yihang
    Jiang Taiyi
    Xia Wei
    Zhang Tong
    Sun Lijun
    Wu Hao
    Qin Hong
    Yun Xinming
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 21 - 21
  • [33] Population pharmacokinetics meta-analysis of plitidepsin (AplidinA®) in cancer subjects
    Nalda-Molina, Ricardo
    Valenzuela, Belen
    Ramon-Lopez, Amelia
    Miguel-Lillo, Bernardo
    Soto-Matos, Arturo
    Perez-Ruixo, Juan Jose
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 97 - 108
  • [34] Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1
    Yee, Ka Lai
    Ouerdani, Aziz
    Claussen, Anetta
    de Greef, Rik
    Wenning, Larissa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [35] A Dose-Response Meta-Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis
    Mandema, J. W.
    Salinger, D. H.
    Baumgartner, S. W.
    Gibbs, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (06) : 828 - 835
  • [36] Systematic review and meta-analysis on the efficacy of methotrexate in rheumatoid arthritis
    Jiang, Xiaofan
    Zeng, Jin
    Chen, Fang
    Li, Juane
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10652 - 10660
  • [37] Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
    Wang, Faping
    Tang, Xiaoju
    Zhu, Min
    Mao, Hui
    Wan, Huajing
    Luo, Fengming
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [38] Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
    Thakre, Neha
    D'Cunha, Ronilda
    Goebel, Aline
    Liu, Wei
    Pang, Yinuo
    Suleiman, Ahmed A.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (06) : 1587 - 1603
  • [39] Population pharmacokinetics and exposure-response modeling analyses of guselkumab in patients with psoriatic arthritis
    Chen, Yang
    Miao, Xin
    Hsu, Chyi-Hung
    Zhuang, Yanli
    Kollmeier, Alexa
    Xu, Zhenhua
    Zhou, Honghui
    Sharma, Amarnath
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (03): : 749 - 760
  • [40] Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: Continuous Model)
    Li, Liang
    Zhang, Yi
    Ma, Lian
    Ji, Ping
    Yim, Sarah
    Chowdhury, Badrul A.
    Doddapaneni, Suresh
    Liu, Jiang
    Wang, Yaning
    Sahajwalla, Chandrahas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1107 - 1125
12345